Security Snapshot

CASTLIGHT HEALTH INC - CL B (CSLT) Institutional Ownership

CUSIP: 14862Q100

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2022

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CSLT - CASTLIGHT HEALTH INC - CL B is tracked under CUSIP 14862Q100.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 102 to 0 between Q4 2021 and Q1 2022.
  • SEC-reported value moved from $143,890,810 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

14862Q100

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
33
Latest
n/a
Rows shown
1-25 of 33
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q1 0 $0 -$136,343,012 0
2021 Q4 93,484,916 $143,890,810 +$3,610,435 $1.54 102
2021 Q3 89,481,542 $140,505,242 +$1,499,397 $1.57 103
2021 Q2 91,144,667 $239,706,486 +$21,094,463 $2.63 101
2021 Q1 87,284,401 $131,794,499 +$6,211,202 $1.51 91
2020 Q4 83,213,446 $108,181,829 +$5,874,372 $1.30 75
2020 Q3 78,125,744 $88,274,733 -$12,866,790 $1.13 74
2020 Q2 91,366,218 $75,768,987 -$3,721,007 $0.83 79
2020 Q1 79,693,976 $57,407,634 -$2,788,767 $0.72 79
2019 Q4 82,956,895 $110,322,161 -$84,717 $1.33 92
2019 Q3 81,784,403 $115,307,363 -$1,160,103 $1.41 97
2019 Q2 80,339,294 $259,417,746 +$14,741,522 $3.23 111
2019 Q1 76,087,245 $285,286,223 +$22,380,782 $3.75 99
2018 Q4 71,472,258 $155,089,408 +$5,798,401 $2.17 102
2018 Q3 68,264,073 $183,577,163 -$3,585,347 $2.70 101
2018 Q2 68,704,984 $291,998,249 +$40,856,756 $4.25 90
2018 Q1 59,411,743 $216,849,704 +$2,800,296 $3.65 78
2017 Q4 58,613,038 $219,807,858 +$6,077,764 $3.75 87
2017 Q3 56,894,867 $244,638,988 +$11,016,458 $4.30 82
2017 Q2 54,371,466 $225,303,162 +$22,784,468 $4.15 82
2017 Q1 49,276,706 $179,532,993 -$8,935,969 $3.65 92
2016 Q4 52,785,757 $261,301,440 +$2,676,705 $4.95 99
2016 Q3 52,126,236 $215,389,835 -$2,347,538 $4.16 94
2016 Q2 52,733,533 $208,682,754 +$1,131,067 $3.96 97
2016 Q1 52,474,386 $174,734,000 +$500,491 $3.33 87
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .